NOTCH1 and cancer: In this cancer, translocations activating transcriptional regulators such as LMO1/2, TAL1/2 and TLX1/3, together with the acquisition of activating mutations in the NOTCH1 gene, are considered hallmarks of the disease (Liu et al., 2017; Pear et al., 1996; Weng et al., 2004).